Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications
Jianwei (Jerry) Fang, Chuchen (Julie) Hou and Jiaying (Kate) Jiang of Zhong Lun Law Firm discuss last year’s most significant legislative and judicial developments in civil and commercial dispute resolution in China
Data platforms that look into supply chains benefit from worsening U.S.-China trade relations; China issues first comprehensive guidelines on anti-corruption compliance for the healthcare sector; and complaints have been filed against TikTok, Shein, and AliExpress alleging they are transferring EU personal data to Chinese authorities in violation of GDPR rules.
Chinese cybersecurity regulator details on the lenient certification method for cross-border data transfer; U.S. issues final rule to prevent “adversarial nations” accessing U.S. citizens’ sensitive personal data; and U.S. to ban venture capital funds from backing certain PLA-affiliated companies
Chinese developer sues Apple for removing its app from the App Store; CSRC requires increased shareholder returns to boost stock prices; and Foreigners are choosing to work remotely instead of moving to China
According to the Foreign Investment Law, the Five-Year Transition Period Deadline for FIEs to complete their adjustments pursuant to the law is approaching. Jianwei (Jerry) Fang, Qianwen (Emily) Gu and Chen (Cissy) Chen of Zhong Lun Law Firm analyze the specific requirements of the law and provide practical guidance for FIEs to identify and carry out relevant adjustments.
Revised Chinese Company Law requires mandatory worker representation in boardrooms; Shanghai's biomedical measures catch the most attention; and Merchants of Pinduoduo's international arm, Temu, struggle to sue the company due to its complex structure.
The amended PRC Company Law will have many, far-reaching effects, including motivating companies to reduce their registered capital in order to optimize capital utilization. Daisy Duan, Yingjie Yang and Cuishi Li of King & Wood Mallesons introduce the motivations and tax implications associated with one possible route: formal capital reductions
The U.S. has added additional Chinese companies to its Entity List and Unverified List; China's State Council has taken steps to encourage foreign venture capital in the tech sector; and Chinese electrolyzer manufacturers are "Europeanizing" their products in anticipation of an EU crackdown.
Alleged receiving of kickbacks by senior executives in China could subject Adidas to Chinese, as well as German and U.S. investigations; U.S. convertible bond market is used to raise funds by Chinese big tech amid IPO restrictions; and EU tariffs may lead to localization of Chinese EV production.
